**Author details**

Juan Esteban Garcia-Robledo1 , Camila Ordóñez-Reyes2,3, Alejandro Ruiz-Patiño2,3, Álvaro Muñoz<sup>4</sup> , Oscar Arrieta5 , Enrique Jiménez7 , Fernando Hakim7 , Diego Gómez7 , Juan Fernando Ramón7 and Andrés F. Cardona2,3,6\*

1 Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, United States

2 Foundation for Clinical and Applied Cancer Research—FICMAC, Bogotá, Colombia

3 Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia

4 Radiation Oncology Department, Carlos Ardila Lülle Cancer Institute—ICCAL, Fundación Santa Fe de Bogotá, Bogotá, Colombia

5 Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), México City, Mexico

6 Direction of Research and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia

7 Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia

\*Address all correspondence to: andres.cardona@clinicadelcountry.com; a\_cardonaz@yahoo.com

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
